EPS Competitors

Stocks . Taiwan . 
Stock . EPS Bio Technology
4183 Stock  TWD 16.00  0.20  1.23%   
EPS Bio Technology competes with UniPharma, Taiwan Advanced, Welgene Biotech, Pharmigene, and IXensor; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing EPS Bio competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of EPS Bio to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out EPS Bio Correlation with its peers.

EPS Bio vs 4170 Correlation

Very good diversification

The correlation between EPS Bio Technology and 4170 is -0.31 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding EPS Bio Technology and 4170 in the same portfolio, assuming nothing else is changed.

Moving together with EPS Stock

  0.874104 Excelsior MedicalPairCorr
  0.686762 Delta Asia InternationalPairCorr
  0.834126 Pacific Hospital SupplyPairCorr

Moving against EPS Stock

  0.875274 Aspeed TechnologyPairCorr
  0.826291 Analog IntegrationsPairCorr
  0.560057 Fubon MSCI TaiwanPairCorr
  0.550050 YuantaP shares TaiwanPairCorr
  0.480051 YuantaP shares TaiwanPairCorr
Hype
Prediction
LowEstimatedHigh
14.6816.2017.72
Details
Intrinsic
Valuation
LowRealHigh
15.1316.6518.17
Details
Naive
Forecast
LowNextHigh
14.4515.9717.49
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
16.0416.5917.14
Details

EPS Bio Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between EPS Bio and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of EPS and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of EPS Bio Technology does not affect the price movement of the other competitor.

High positive correlations

6734
+ 0.72
6621
6734
+ 0.69
1781
7595
+ 0.61
7607
1781
+ 0.56
6621
1781
+ 0.5
6661
6661
+ 0.49
6621
  

High negative correlations

7595
- 0.32
1781
6797
- 0.25
6621
1781
- 0.23
4115
4170
- 0.23
6621
6734
- 0.22
6797
7595
- 0.21
6621

Risk-Adjusted Indicators

There is a big difference between EPS Stock performing well and EPS Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze EPS Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
7607  1.72 (0.08) 0.00  0.77  0.00 
 0.00 
 4.63 
(4.65)
 13.34 
6621  1.16  0.17  0.08  0.48  1.32 
(1.44)
 2.81 
(2.02)
 9.14 
6797  2.23  0.04 (0.01)(0.19) 3.35 
(2.50)
 4.65 
(7.10)
 22.74 
4115  1.33  0.03  0.00  0.16  1.49 
(2.30)
 3.95 
(3.57)
 8.68 
6661  0.89 (0.05) 0.00  0.24  0.00 
 0.00 
 2.33 
(2.05)
 7.33 
1781  0.76 (0.02) 0.00 (0.06) 0.00 
 0.00 
 0.91 
(1.33)
 10.60 
7595  1.50 (0.10) 0.00 (0.29) 0.00 
 0.00 
 4.12 
(3.82)
 7.95 
6734  2.00 (0.15) 0.00  0.36  0.00 
 0.00 
 4.13 
(4.76)
 15.82 
6758  0.64 (0.07) 0.00 (0.48) 0.00 
 0.00 
 1.62 
(3.97)
 8.78 
4170  2.28  0.06 (0.02)(0.01) 2.96 
(2.52)
 4.44 
(3.81)
 12.49 

EPS Bio Competitive Analysis

The better you understand EPS Bio competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, EPS Bio's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across EPS Bio's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
4183 7607 6621 6797 4115 6661 1781 7595 6734 6758
 1.23 
 16.00 
EPS
 3.66 
 18.45 
7607
 5.34 
 13.80 
UniPharma
 1.31 
 15.10 
Taiwan
 3.95 
 8.42 
Sunder
 0.79 
 18.90 
Welgene
 2.90 
 12.40 
Health
 5.13 
 10.05 
Pharmigene
 3.47 
 6.56 
IXensor
 0.52 
 38.50 
6758
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Not too volatile
Somewhat reliable
Somewhat reliable
Very steady
Not too volatile
Not too volatile
Slightly risky
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Fair
Weakest
Weak
Weakest
Weakest
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Unknown
Low
Low
Unknown
Low
Fair
Low
High
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Hold
Strong Sell
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Cautious Hold
Strong Sell
Strong Sell
Current Ratio
2.88
N/A
9.6
2.62
N/A
3.89
N/A
14.16
4.71
N/A
Profit Margin
9.33
N/A
-39.93
33.89
N/A
N/A
N/A
-11.06
N/A
N/A
EBITDA
46.92 M
N/A
(15.17 M)
809.69 M
N/A
33.05 M
N/A
(8.73 M)
(92.19 M)
N/A
Operating Margin
7.56
N/A
-14.87
40.21
N/A
N/A
N/A
-13.68
-696.46
N/A
Current Valuation
345.41 M
N/A
286.35 M
945.75 M
N/A
N/A
N/A
717.33 M
737.24 M
N/A
Price To Book
1.36
N/A
1.23
1.34
N/A
N/A
N/A
2.49
9.15
N/A
Beta
1.3
N/A
1.18
N/A
N/A
0.33
N/A
N/A
0.99
N/A
Number Of Employees
121
N/A
42
N/A
N/A
11
7
N/A
N/A
N/A
Shares Outstanding
23.8 M
N/A
35.2 M
23.17 M
N/A
N/A
N/A
43.47 M
49.41 M
13.47 M
Cash Flow From Operations
37.37 M
N/A
(17.18 M)
789.25 M
N/A
34.62 M
N/A
(12.78 M)
(70.8 M)
N/A
Total Debt
141.01 M
N/A
16.82 M
553.23 M
N/A
30.42 M
N/A
21.63 M
3.8 M
N/A
Return On Equity
14.88
N/A
-14.19
50.59
N/A
N/A
N/A
-4.15
-89.84
N/A
Z Score
1.2
N/A
16.2
1.2
N/A
11.4
N/A
28.2
N/A
N/A
Return On Asset
4.42
N/A
-2.96
19.95
N/A
N/A
N/A
-2.79
-52.32
N/A
Book Value Per Share
12.43
N/A
10.77
44.83
N/A
13.6
N/A
9.42
1.6
N/A
Debt To Equity
47.6
N/A
0.044
0.35
N/A
0.095
N/A
0.052
0.047
N/A
Last Dividend Paid
0.7
N/A
N/A
6.0
N/A
1.1
N/A
N/A
N/A
2.5
Market Capitalization
402.22 M
N/A
464.65 M
1.39 B
N/A
591.92 M
538.08 M
1.02 B
723.78 M
693.76 M
Price To Earning
9.74
N/A
N/A
1.98
N/A
24.19
N/A
N/A
N/A
N/A
Price To Sales
0.9
N/A
3.35
0.74
N/A
N/A
N/A
10.06
51.55
N/A
Net Income
41.47 M
N/A
(55.35 M)
636.96 M
N/A
22.38 M
N/A
(11.21 M)
(89.69 M)
N/A
Earnings Per Share
1.74
N/A
-1.57
30.37
N/A
1.05
N/A
-0.33
-1.55
N/A
Revenue
444.68 M
N/A
138.64 M
1.88 B
N/A
N/A
N/A
101.35 M
14.04 M
N/A
Cash And Equivalents
202.58 M
N/A
188.09 M
1.37 B
N/A
239.66 M
N/A
297.48 M
31.28 M
N/A
Cash Per Share
8.51
N/A
5.34
45.56
N/A
10.28
N/A
6.84
0.6
N/A
Gross Profit
95.71 M
N/A
69.32 M
1.07 B
N/A
N/A
N/A
44.29 M
4.5 M
N/A
Day Typical Price
16.03
18.68
13.57
15.02
8.42
18.9
12.3
10.03
6.53
38.48
Accumulation Distribution
167.7
1758.55
13543.07
0.0552
N/A
N/A
731.98
0.005
18238.69
0.0013
Market Facilitation Index
0.0
0.0
0.0
0.85
N/A
N/A
0.0
0.05
0.0
0.05
Daily Balance Of Power
(2.00)
(1.00)
1.0
(0.24)
9.2 T
0
1.166667
9.8
0.3438
4.0
Period Momentum Indicator
(0.20)
(0.70)
0.7
(0.20)
0.32
(0.15)
0.35
0.49
0.22
0.2
Rate Of Daily Change
0.99
0.96
1.05
0.99
1.04
0.99
1.03
1.05
1.03
1.01
Day Median Price
16.05
18.8
13.45
14.98
8.42
18.9
12.25
10.03
6.51
38.48
Price Action Indicator
(0.15)
(0.70)
0.7
0.025
0.16
(0.07)
0.33
0.27
0.16
0.13
Relative Strength Index
35.37
N/A
N/A
47.23
N/A
51.17
64.1
N/A
53.25
N/A
Coefficient Of Variation
(921.39)
(3,114)
769.25
8593.41
2750.12
(1,978)
(103,901)
(3,005)
(1,605)
(2,371)
Mean Deviation
1.0
1.72
1.16
2.23
1.33
0.8949
0.7602
1.5
2.0
0.6434
Jensen Alpha
(0.20)
(0.08)
0.1722
0.0421
0.0348
(0.05)
(0.02)
(0.1)
(0.15)
(0.07)
Total Risk Alpha
(0.31)
(0.33)
0.0495
(0.30)
(0.12)
(0.20)
(0.15)
(0.27)
(0.45)
(0.19)
Sortino Ratio
N/A
N/A
0.0783
(0.01)
(0)
N/A
N/A
N/A
N/A
N/A
Downside Variance
N/A
N/A
2.88
17.18
4.75
N/A
N/A
N/A
N/A
N/A
Standard Deviation
1.49
2.57
1.62
3.52
1.92
1.29
1.53
2.08
2.85
1.32
Kurtosis
1.99
2.75
1.81
3.23
0.4731
1.6
26.1
0.1314
1.87
7.22
Potential Upside
2.64
4.63
2.81
4.65
3.95
2.33
0.9132
4.12
4.13
1.62
Treynor Ratio
(0.43)
0.7661
0.4758
(0.19)
0.1637
0.2433
(0.06)
(0.29)
0.3612
(0.48)
Maximum Drawdown
8.43
13.34
9.14
22.74
8.68
7.33
10.6
7.95
15.82
8.78
Variance
2.21
6.59
2.64
12.39
3.67
1.68
2.33
4.31
8.13
1.74
Market Risk Adjusted Performance
(0.42)
0.7761
0.4858
(0.18)
0.1737
0.2533
(0.05)
(0.28)
0.3712
(0.47)
Risk Adjusted Performance
(0.07)
(0.02)
0.1007
0.0164
0.0328
(0.03)
0.0045
(0.02)
(0.04)
(0.03)
Skewness
0.5644
0.7947
0.1948
0.2005
0.1939
0.4578
4.11
0.3551
0.2633
(0.84)
Semi Deviation
N/A
N/A
1.32
3.35
1.49
N/A
N/A
N/A
N/A
N/A
Information Ratio
(0.16)
(0.06)
0.0817
(0.01)
(0)
(0.11)
(0.05)
(0.07)
(0.09)
(0.10)
Value At Risk
(2.35)
(4.65)
(2.02)
(7.10)
(3.57)
(2.05)
(1.33)
(3.82)
(4.76)
(3.97)
Expected Short fall
N/A
N/A
(1.44)
(2.50)
(2.30)
N/A
N/A
N/A
N/A
N/A
Downside Deviation
N/A
N/A
1.7
4.15
2.18
N/A
N/A
N/A
N/A
N/A
Semi Variance
N/A
N/A
1.75
11.25
2.21
N/A
N/A
N/A
N/A
N/A

EPS Bio Competition Performance Charts

Five steps to successful analysis of EPS Bio Competition

EPS Bio's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by EPS Bio Technology in relation to its competition. EPS Bio's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of EPS Bio in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact EPS Bio's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to EPS Bio Technology, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your EPS Bio position

In addition to having EPS Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Preferred Stock ETFs Thematic Idea Now

Preferred Stock ETFs
Preferred Stock ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Preferred Stock ETFs theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Preferred Stock ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for EPS Stock Analysis

When running EPS Bio's price analysis, check to measure EPS Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EPS Bio is operating at the current time. Most of EPS Bio's value examination focuses on studying past and present price action to predict the probability of EPS Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EPS Bio's price. Additionally, you may evaluate how the addition of EPS Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY